Received Jul 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
fever 100.3; chills; excessive urination; This non-serious case was reported by a consumer and described the occurrence of fever in a 70-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 09-MAY-2025, the patient received Shingles vaccine .5 ml. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: fever 100.3), chills (Verbatim: chills) and micturition disorder (Verbatim: excessive urination). The outcome of the fever, chills and micturition disorder were not resolved. It was unknown if the reporter considered the fever, chills and micturition disorder to be related to Shingles vaccine. It was unknown if the company considered the fever, chills and micturition disorder to be related to Shingles vaccine. Additional Information: GSK receipt date: 19-JUL-2025 The patient reported that after the Shingrix vaccine she experienced fever 100.3, chills and excessive urination. The patient had no previous medical history The expiry date of Shingles vaccine was unknown.
Test Name: Body temperature; Result Unstructured Data: (Test Result:100.3,Unit:unknown,Normal Low:,Normal High:)